HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.
Cancer Immunol Immunother
; 58(6): 967-76, 2009 Jun.
Article
in En
| MEDLINE
| ID: mdl-18979097
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Membrane Glycoproteins
/
Antigens, CD
/
Immunotherapy
/
Lung Neoplasms
/
Antibody-Dependent Cell Cytotoxicity
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2009
Type:
Article
Affiliation country:
Japan